Hematuria screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Adnan Ezici, M.D[2]
Overview
There is insufficient evidence to recommend routine screening for bladder cancer in patients with hematuria. However, according to the recently developed scoring system known as Haematuria Cancer Risk Score (HCRS), screening for bladder cancer in patients with hematuria with high HCRS score (based on age, sex, smoking history, and type of hematuria) might be recommended.
Screening
There is insufficient evidence to recommend routine screening for bladder cancer in patients with hematuria.
- According to the U.S. Preventive Services Task Force (USPSTF), screening for bladder cancer in patients with hematuria is not recommended because of the insufficient evidence of benefit against harm. However, according to the recently developed scoring system known as Haematuria Cancer Risk Score (HCRS), screening for bladder cancer in patients with hematuria with high HCRS score (based on age, sex, smoking history, and type of hematuria) might be recommended.[1]
References
- ↑ Ingelfinger, Julie R.; Longo, Dan L. (2021). “Hematuria in Adults”. New England Journal of Medicine. 385 (2): 153–163. doi:10.1056/NEJMra1604481. ISSN 0028-4793.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
